Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies
2020
277 citations
Journal Article
bronze Open Access
Field-Weighted Citation Impact:
26.00
RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies | Researchclopedia
·
Loxo Oncology at Lilly (United States)
Satoshi Yoda
·
Massachusetts General Hospital
Justin F. Gainor
·
Massachusetts General Hospital
Lecia V. Sequist
·
Massachusetts General Hospital
Geoffrey R. Oxnard
·
Dana-Farber Cancer Institute
Oliver Gautschi
·
Luzerner Kantonsspital
Alexander Drilon
·
Memorial Sloan Kettering Cancer Center
Vivek Subbiah
·
The University of Texas MD Anderson Cancer Center
Christine Khoo
·
Peter MacCallum Cancer Centre
Edward Y. Zhu
·
Loxo Oncology at Lilly (United States)
Michele Nguyen
·
Loxo Oncology at Lilly (United States)
Dahlia Henry
·
Loxo Oncology at Lilly (United States)
Kevin R. Condroski
·
Loxo Oncology at Lilly (United States)
Gabrielle R. Kolakowski
·
Loxo Oncology at Lilly (United States)
Eliana B Gómez
·
Loxo Oncology at Lilly (United States)
Joshua A. Ballard
·
Loxo Oncology at Lilly (United States)
Andrew T. Metcalf
·
Loxo Oncology at Lilly (United States)
James F. Blake
·
Array BioPharma (United States)
Sarah‐Jane Dawson
·
University of Melbourne
Wayne Blosser
·
Eli Lilly (United States)
Louis F. Stancato
·
Eli Lilly (United States)
Barbara J. Brandhuber
·
Loxo Oncology at Lilly (United States)
Steve Andrews
·
Loxo Oncology at Lilly (United States)
Bruce G. Robinson
·
Royal North Shore Hospital
S. Michael Rothenberg
·
Loxo Oncology at Lilly (United States)